Deep vein thrombosis during long-term surveillance of patients with liver transplantation
ConclusionsThere are no specific guideline recommendations regarding acute DVT treatment in long-term surveillance after liver transplantation. Low molecular weight heparin (LMWH), unfractionated heparin (UFH) and vitamin K antagonist (VKA) are the anticoagulants used in specific complications post-transplantation. The safety and the efficacy of direct anticoagulants in liver transplantation recipients need to be assessed in future trials. Given that long-term survival of liver transplantation is much improved, complications associated with transplantation and ageing require appropriate cardiovascular guidelines.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Databases & Libraries | Diabetes | Eating Disorders & Weight Management | Endocrinology | General Medicine | Heart | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Hormones | Inflammatory Bowel Disease | Ireland Health | Liver | Liver Cancer | Liver Transplant | Obesity | Science | Study | Thrombosis | Transplant Surgery | Transplants | Urology & Nephrology | Vitamin K | Vitamins